Apogee Therapeutics, Inc. (APGE) shares fell 6.66 percent to $73.98, down $5.26 on Tuesday, after the company announced a public stock offering that could raise significant new capital.
The stock is currently trading at $73.98 compared with its previous close of $79.24. Shares opened at $79.48 and traded between $73.50 and $79.48 during the session on the Nasdaq. Trading volume reached about 431,566 shares, below the average volume of about 961,793 shares.
Apogee said it launched an underwritten public offering of $300 million in common stock and expects to grant underwriters an option to purchase up to an additional $45 million of shares.
The stock has traded in a 52-week range of $26.20 to $84.56.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.